Free Trial
→ Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next (From Paradigm Press) (Ad)tc pixel
LON:GSK

GSK 7/30/2025 Earnings Report

GSK logo
GBX 1,876.50 -9.50 (-0.50%)
As of 05:06 AM Eastern
ProfileEarnings HistoryForecast

GSK EPS Results

Actual EPS
GBX 75.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GSK Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GSK Announcement Details

Quarter
Date
7/30/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GSK Earnings Headlines

GSK plans to sell chronic hepatitis B drug in China through Sino Biopharm
May 11 at 12:01 PM  |  msn.comhttps://www.msn.com/en-us/health/other/gsk-plans-to-sell-chronic-hepatitis-b-drug-in-china-through-sino-biopharm/ar-AA22ViaL
GSK spends $1bn on rights to SiranBio’s metabolic oligonucleotide
May 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/gsk-spends-1bn-rights-siranbio-171314334.html
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The Financial Times estimates this move could help unleash $100 trillion in new wealth. Billionaire investors John Paulson, Ray Dalio, and Paul Tudor Jones are already said to be preparing. The window to get ahead of this may be closing.tc pixel
 |  Paradigm Press (Ad)
Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults
May 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/julie-bowen-ty-burrell-team-120000816.html
GSK's (GSK) Hold Rating Reaffirmed at Deutsche Bank Aktiengesellschaft
May 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30763317
GSK (LON:GSK) Price Target Cut to GBX 2,100 by Analysts at Citigroup
May 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30763303
See More GSK Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GSK? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GSK and other key companies, straight to your email.

About GSK

GSK (LON:GSK), together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

View GSK Profile
Earnings Tools